English

ISTA PHARMACEUTICALS INC

EDGAR

Quarterly report (10-Q) · filed 2012-05-04

60 filing records in this dataset, filed from 2000-11-14 to 2012-05-04. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

34 million Unit12

2012 Q1 · Unit12

Exact inputs and evidence

Revenue: 34012000 Unit12 Source

Operating margin

-4.74%

2012 Q1 · %

Exact inputs and evidence

Operating Income: -1611000 Unit12 Source
Revenue: 34012000 Unit12 Source

Operating cash flow

-9.01 million Unit12

2012 Q1 · Unit12

Exact inputs and evidence

Operating Cash Flow: -9012000 Unit12 Source

Free cash flow

-9.51 million Unit12

2012 Q1 · Unit12

Exact inputs and evidence

Operating Cash Flow: -9012000 Unit12 Source
Capital Expenditure: 496000 Unit12 Source

Cash and cash equivalents: 53.7 million Unit12 2012-03-31 Source
Exact value

53692000 Unit12
Long-term debt including current maturities: Not available
Shares outstanding: 41.9 million Unit1 2012-03-31 Source
Exact value

41906000 Unit1

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2012-05-04.

Financial data available through: 2011-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2011-12-31
Operating income: 3 of 11 periods available· newest 2011-12-31
Net income: 3 of 11 periods available· newest 2011-12-31
Operating cash flow: 3 of 11 periods available· newest 2011-12-31
Capital expenditure: 3 of 11 periods available· newest 2011-12-31
Total assets: 2 of 11 periods available· newest 2011-12-31
Total liabilities: 2 of 11 periods available· newest 2011-12-31
Current assets: 2 of 11 periods available· newest 2011-12-31
Current liabilities: 2 of 11 periods available· newest 2011-12-31
Cash and cash equivalents: 4 of 11 periods available· newest 2011-12-31
long term debt: No compatible figures in this window
Shares outstanding: 2 of 11 periods available· newest 2011-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+2.4%

Prior period

Unit12 156.53 million

2010-01-01 – 2010-12-31
Current period

Unit12 160.33 million

2011-01-01 – 2011-12-31

Exact inputs and evidence

160333000 − 156525000 = 3808000 Unit12

156525000 Unit12 · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
160333000 Unit12 · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ISTA PHARMACEUTICALS INC · 2011-12-31 ISTA PHARMACEUTICALS INC (edgar:930553) Year-over-year change in Revenue: 3808000 Unit12 Concept: fundies:Revenue Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/930553?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 160333000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/930553/000119312512081708/ista-20111231.xml#366880 Filing: 000119312512081708 Input fundies:Revenue: 156525000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/930553/000119312512081708/ista-20111231.xml#366755 Filing: 000119312512081708
The citation records this snapshot. The page link may show a newer release later.
Net income
−Unit12 51.31 million

Prior period

−Unit12 5.3 million

2010-01-01 – 2010-12-31
Current period

−Unit12 56.61 million

2011-01-01 – 2011-12-31

Exact inputs and evidence

-56606000 − -5300000 = -51306000 Unit12

-5300000 Unit12 · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
-56606000 Unit12 · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ISTA PHARMACEUTICALS INC · 2011-12-31 ISTA PHARMACEUTICALS INC (edgar:930553) Year-over-year change in Net income: -51306000 Unit12 Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/930553?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -56606000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/930553/000119312512081708/ista-20111231.xml#192065 Filing: 000119312512081708 Input fundies:NetIncome: -5300000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/930553/000119312512081708/ista-20111231.xml#191728 Filing: 000119312512081708
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-112.4%

Prior period

Unit12 28.1 million

2010-01-01 – 2010-12-31
Current period

−Unit12 3.49 million

2011-01-01 – 2011-12-31

Exact inputs and evidence

-3486000 − 28096000 = -31582000 Unit12

28096000 Unit12 · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
-3486000 Unit12 · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ISTA PHARMACEUTICALS INC · 2011-12-31 ISTA PHARMACEUTICALS INC (edgar:930553) Year-over-year change in Operating cash flow: -31582000 Unit12 Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/930553?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -3486000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/930553/000119312512081708/ista-20111231.xml#191197 Filing: 000119312512081708 Input fundies:OperatingCashFlow: 28096000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/930553/000119312512081708/ista-20111231.xml#191005 Filing: 000119312512081708
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-44.5%

Prior period

Unit12 3.44 million

2010-01-01 – 2010-12-31
Current period

Unit12 1.91 million

2011-01-01 – 2011-12-31

Exact inputs and evidence

1910000 − 3440000 = -1530000 Unit12

3440000 Unit12 · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
1910000 Unit12 · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ISTA PHARMACEUTICALS INC · 2011-12-31 ISTA PHARMACEUTICALS INC (edgar:930553) Year-over-year change in Capital expenditure: -1530000 Unit12 Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/930553?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1910000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/930553/000119312512081708/ista-20111231.xml#276969 Filing: 000119312512081708 Input fundies:CapitalExpenditure: 3440000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/930553/000119312512081708/ista-20111231.xml#276778 Filing: 000119312512081708
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2011 2011-01-01 – 2011-12-31

Revenue Unit12 160.33 million 100% of revenue
Cost of revenue Unit12 39.11 million 24% of revenue
Operating expenses Unit12 121.21 million 76% of revenue
Operating income Unit12 19,000 0% of revenue
Tax, interest and other Derived Unit12 56.63 million 35% of revenue
Net income −Unit12 56.61 million −35% of revenue

Cash

Operating cash flow −Unit12 3.49 million −2.2% of revenue
Capital expenditure Unit12 1.91 million 1.2% of revenue
Free cash flow Derived −Unit12 5.4 million −3.4% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2009 Net loss: net income was −52% of revenue.
2010 Net loss: net income was −3.4% of revenue.
2011 Net loss: net income was −35% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2009 2009-01-01 – 2009-12-31	110648000	108559000 Derived	2089000	59843000 Derived	-57754000	2670000 Derived	Source 2009-01-01 – 2009-12-31: 110648000 Unit12 Inspect Revenue Open source 2009-01-01 – 2009-12-31: 2089000 Unit12 Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -57754000 Unit12 Inspect Net Income Open source 2009-01-01 – 2009-12-31: 3987000 Unit12 Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 1317000 Unit12 Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	156525000	146168000 Derived	10357000	15657000 Derived	-5300000	24656000 Derived	Source 2010-01-01 – 2010-12-31: 156525000 Unit12 Inspect Revenue Open source 2010-01-01 – 2010-12-31: 10357000 Unit12 Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -5300000 Unit12 Inspect Net Income Open source 2010-01-01 – 2010-12-31: 28096000 Unit12 Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 3440000 Unit12 Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	160333000	160314000 Derived	19000	56625000 Derived	-56606000	-5396000 Derived	Source 2011-01-01 – 2011-12-31: 160333000 Unit12 Inspect Revenue Open source 2011-01-01 – 2011-12-31: 19000 Unit12 Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -56606000 Unit12 Inspect Net Income Open source 2011-01-01 – 2011-12-31: -3486000 Unit12 Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 1910000 Unit12 Inspect Capital Expenditure Open source

Amounts are exact, in Unit12.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit12 160.3M 2011

Values and sources

Revenue values and source evidence
Period	Series	Value(Unit12)	Source evidence
20092009-12-31	Revenue	110648000	Revenue: 110648000 Open source
20102010-12-31	Revenue	156525000	Revenue: 156525000 Open source
20112011-12-31	Revenue	160333000	Revenue: 160333000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

2.4% 2011

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Year over year	No prior comparable period	Revenue: 110648000 Open source
20102010-12-31	Year over year	41.5%	Revenue: 156525000 Open source Revenue: 110648000 Open source
20112011-12-31	Year over year	2.4%	Revenue: 160333000 Open source Revenue: 156525000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 0% 2011

Net margin -35.3% 2011

Free cash flow margin -3.4% 2011

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Operating margin	1.9%	Operating Income: 2089000 Open source Revenue: 110648000 Open source
20102010-12-31	Operating margin	6.6%	Operating Income: 10357000 Open source Revenue: 156525000 Open source
20112011-12-31	Operating margin	0%	Operating Income: 19000 Open source Revenue: 160333000 Open source
20092009-12-31	Net margin	-52.2%	Net Income: -57754000 Open source Revenue: 110648000 Open source
20102010-12-31	Net margin	-3.4%	Net Income: -5300000 Open source Revenue: 156525000 Open source
20112011-12-31	Net margin	-35.3%	Net Income: -56606000 Open source Revenue: 160333000 Open source
20092009-12-31	Free cash flow margin	2.4%	Revenue: 110648000 Open source Operating Cash Flow: 3987000 Open source Capital Expenditure: 1317000 Open source
20102010-12-31	Free cash flow margin	15.8%	Revenue: 156525000 Open source Operating Cash Flow: 28096000 Open source Capital Expenditure: 3440000 Open source
20112011-12-31	Free cash flow margin	-3.4%	Revenue: 160333000 Open source Operating Cash Flow: -3486000 Open source Capital Expenditure: 1910000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

Unit12 -3.5M 2011

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(Unit12)	Source evidence
20092009-12-31	Operating cash flow	3987000	Operating Cash Flow: 3987000 Open source
20102010-12-31	Operating cash flow	28096000	Operating Cash Flow: 28096000 Open source
20112011-12-31	Operating cash flow	-3486000	Operating Cash Flow: -3486000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Unit12 -5.4M 2011

Values and sources

Free cash flow values and source evidence
Period	Series	Value(Unit12)	Source evidence
20092009-12-31	Free cash flow	2670000	Operating Cash Flow: 3987000 Open source Capital Expenditure: 1317000 Open source
20102010-12-31	Free cash flow	24656000	Operating Cash Flow: 28096000 Open source Capital Expenditure: 3440000 Open source
20112011-12-31	Free cash flow	-5396000	Operating Cash Flow: -3486000 Open source Capital Expenditure: 1910000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

132.1% 2011

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2009-12-31	Liabilities / assets	Not reported	No source recorded
20102010-12-31	Liabilities / assets	158.9%	Total Liabilities: 213337000 Open source Total Assets: 134240000 Open source
20112011-12-31	Liabilities / assets	132.1%	Total Liabilities: 202164000 Open source Total Assets: 153091000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.02× 2011

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2009-12-31	Current assets / current liabilities	Not reported	No source recorded
20102010-12-31	Current assets / current liabilities	1.15×	Current Assets: 121858000 Open source Current Liabilities: 106036000 Open source
20112011-12-31	Current assets / current liabilities	1.02×	Current Assets: 140119000 Open source Current Liabilities: 137854000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2009 2009-01-01 – 2009-12-31	−Unit12 57.75 million Exact value Exact value: -57754000 Unit12 2009-01-01 – 2009-12-31: -57754000 Unit12 Inspect Net Income Open source Share or cite Citation for Net Income · ISTA PHARMACEUTICALS INC · 2009-12-31 ISTA PHARMACEUTICALS INC (edgar:930553) Net Income: -57754000 Unit12 Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/930553/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=Unit12&dimensions= Input fundies:NetIncome: -57754000 Unit12 (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/930553/000119312512081708/ista-20111231.xml#191389 Filing: 000119312512081708 The citation records this snapshot. The page link may show a newer release later.	Unit12 3.99 million Exact value Exact value: 3987000 Unit12 2009-01-01 – 2009-12-31: 3987000 Unit12 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ISTA PHARMACEUTICALS INC · 2009-12-31 ISTA PHARMACEUTICALS INC (edgar:930553) Operating Cash Flow: 3987000 Unit12 Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/930553/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=Unit12&dimensions= Input fundies:OperatingCashFlow: 3987000 Unit12 (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/930553/000119312512081708/ista-20111231.xml#190814 Filing: 000119312512081708 The citation records this snapshot. The page link may show a newer release later.	Unit12 1.32 million Exact value Exact value: 1317000 Unit12 2009-01-01 – 2009-12-31: 1317000 Unit12 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ISTA PHARMACEUTICALS INC · 2009-12-31 ISTA PHARMACEUTICALS INC (edgar:930553) Capital Expenditure: 1317000 Unit12 Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/930553/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=Unit12&dimensions= Input fundies:CapitalExpenditure: 1317000 Unit12 (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/930553/000119312512081708/ista-20111231.xml#276587 Filing: 000119312512081708 The citation records this snapshot. The page link may show a newer release later.	Unit12 2.67 million Calculation and evidence 3987000 − 1317000 Unit12 Exact free cash flow: 2670000 Unit12 2009-01-01 – 2009-12-31: 3987000 Unit12 · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 1317000 Unit12 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ISTA PHARMACEUTICALS INC · 2009-12-31 ISTA PHARMACEUTICALS INC (edgar:930553) Free cash flow: 2670000 Unit12 Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/930553?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 3987000 Unit12 (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/930553/000119312512081708/ista-20111231.xml#190814 Filing: 000119312512081708 Input fundies:CapitalExpenditure: 1317000 Unit12 (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/930553/000119312512081708/ista-20111231.xml#276587 Filing: 000119312512081708 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−Unit12 5.3 million Exact value Exact value: -5300000 Unit12 2010-01-01 – 2010-12-31: -5300000 Unit12 Inspect Net Income Open source Share or cite Citation for Net Income · ISTA PHARMACEUTICALS INC · 2010-12-31 ISTA PHARMACEUTICALS INC (edgar:930553) Net Income: -5300000 Unit12 Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/930553/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=Unit12&dimensions= Input fundies:NetIncome: -5300000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/930553/000119312512081708/ista-20111231.xml#191728 Filing: 000119312512081708 The citation records this snapshot. The page link may show a newer release later.	Unit12 28.1 million Exact value Exact value: 28096000 Unit12 2010-01-01 – 2010-12-31: 28096000 Unit12 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ISTA PHARMACEUTICALS INC · 2010-12-31 ISTA PHARMACEUTICALS INC (edgar:930553) Operating Cash Flow: 28096000 Unit12 Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/930553/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=Unit12&dimensions= Input fundies:OperatingCashFlow: 28096000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/930553/000119312512081708/ista-20111231.xml#191005 Filing: 000119312512081708 The citation records this snapshot. The page link may show a newer release later.	Unit12 3.44 million Exact value Exact value: 3440000 Unit12 2010-01-01 – 2010-12-31: 3440000 Unit12 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ISTA PHARMACEUTICALS INC · 2010-12-31 ISTA PHARMACEUTICALS INC (edgar:930553) Capital Expenditure: 3440000 Unit12 Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/930553/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=Unit12&dimensions= Input fundies:CapitalExpenditure: 3440000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/930553/000119312512081708/ista-20111231.xml#276778 Filing: 000119312512081708 The citation records this snapshot. The page link may show a newer release later.	Unit12 24.66 million Calculation and evidence 28096000 − 3440000 Unit12 Exact free cash flow: 24656000 Unit12 2010-01-01 – 2010-12-31: 28096000 Unit12 · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 3440000 Unit12 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ISTA PHARMACEUTICALS INC · 2010-12-31 ISTA PHARMACEUTICALS INC (edgar:930553) Free cash flow: 24656000 Unit12 Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/930553?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 28096000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/930553/000119312512081708/ista-20111231.xml#191005 Filing: 000119312512081708 Input fundies:CapitalExpenditure: 3440000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/930553/000119312512081708/ista-20111231.xml#276778 Filing: 000119312512081708 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−Unit12 56.61 million Exact value Exact value: -56606000 Unit12 2011-01-01 – 2011-12-31: -56606000 Unit12 Inspect Net Income Open source Share or cite Citation for Net Income · ISTA PHARMACEUTICALS INC · 2011-12-31 ISTA PHARMACEUTICALS INC (edgar:930553) Net Income: -56606000 Unit12 Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/930553/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=Unit12&dimensions= Input fundies:NetIncome: -56606000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/930553/000119312512081708/ista-20111231.xml#192065 Filing: 000119312512081708 The citation records this snapshot. The page link may show a newer release later.	−Unit12 3.49 million Exact value Exact value: -3486000 Unit12 2011-01-01 – 2011-12-31: -3486000 Unit12 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ISTA PHARMACEUTICALS INC · 2011-12-31 ISTA PHARMACEUTICALS INC (edgar:930553) Operating Cash Flow: -3486000 Unit12 Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/930553/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=Unit12&dimensions= Input fundies:OperatingCashFlow: -3486000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/930553/000119312512081708/ista-20111231.xml#191197 Filing: 000119312512081708 The citation records this snapshot. The page link may show a newer release later.	Unit12 1.91 million Exact value Exact value: 1910000 Unit12 2011-01-01 – 2011-12-31: 1910000 Unit12 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ISTA PHARMACEUTICALS INC · 2011-12-31 ISTA PHARMACEUTICALS INC (edgar:930553) Capital Expenditure: 1910000 Unit12 Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/930553/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=Unit12&dimensions= Input fundies:CapitalExpenditure: 1910000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/930553/000119312512081708/ista-20111231.xml#276969 Filing: 000119312512081708 The citation records this snapshot. The page link may show a newer release later.	−Unit12 5.4 million Calculation and evidence -3486000 − 1910000 Unit12 Exact free cash flow: -5396000 Unit12 2011-01-01 – 2011-12-31: -3486000 Unit12 · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 1910000 Unit12 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ISTA PHARMACEUTICALS INC · 2011-12-31 ISTA PHARMACEUTICALS INC (edgar:930553) Free cash flow: -5396000 Unit12 Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/930553?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3486000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/930553/000119312512081708/ista-20111231.xml#191197 Filing: 000119312512081708 Input fundies:CapitalExpenditure: 1910000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/930553/000119312512081708/ista-20111231.xml#276969 Filing: 000119312512081708 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

60 filings · 465 latest values · 465 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000930553, 930553, edgar:930553

Also known as ISTA PHARMACEUTICALS INC

ISTA PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2011 2011-01-01 – 2011-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation